Tag: aromataseInhibitors

Aromatase inhibitors: Drugs designed to inhibit the action of the enzyme aromatase, which converts androgens into estrogens within the body. Aromatase inhibitors are a type of first-line endocrine treatment for estrogen receptor positive (ER+) breast cancer.

Articles

News

08/26/17
Walking can reduce aromatase inhibitor-induced joint pain
01/12/15
Early birth control pill use is linked to recurrence of premenopausal breast cancer
09/08/13
Not completing anti-estrogen treatment linked to sharply higher risk of recurrence
04/30/13
Unpleasant side effects of anti-estrogens can indicate treatment is working
12/31/12
Treatment with Femara after tamoxifen can worsen cholesterol profile
07/19/12
Aromatase inhibitors are less effective in reducing estrogen in women with high BMI
07/15/12
Reduction in breast density shows endocrine treatment is working
05/13/12
A story of long-term stage IV HER2+ breast cancer survival
03/08/12
Heart drug digoxin (digitalis) increases risk of breast cancer
02/06/12
Soy supplements do not reduce breast cancer risk and could be harmful
01/12/12
How much red wine is safe for breast cancer survivors?
10/19/11
Tumor response to anti-estrogen treatment before surgery is influenced by BMI and race
09/07/11
Strongly estrogen positive lobular breast cancer responds well to neoadjuvant Femara
08/17/11
Genistein stimulates aromatase activity and ER+ breast cancer cell growth
07/31/11
High dose vitamin D reduces musculoskeletal symptoms in women taking Arimidex
07/17/11
Increasingly severe side effects of aromatase inhibitors may make tamoxifen first the best strategy
07/09/11
Vitamin D supplementation might interfere with aromatase inhibitor treatment
06/27/11
Chemotherapy might have different effectiveness in lobular compared to ductal breast cancer
06/09/11
Patients with ER-/PR+ breast cancer benefit from endocrine therapy
03/23/11
Obesity increases inflammation and estrogen production in breast tissue
03/01/11
Aromatase inhibitor only or after tamoxifen are both effective treatments
12/28/10
Vitamin D levels often low even in breast cancer survivors taking supplements
11/18/10
Aromatase inhibitors have numerous side effects in addition to musculoskeletal symptoms
07/19/10
Women with high BMI may benefit less from hormonal treatments
06/12/10
Cognitive function improves after completion of both Femara and tamoxifen treatment
03/07/10
Weight gain can increase hot flashes in breast cancer survivors on aromatase inhibitors
02/20/10
Vitamin D deficiency promotes growth of breast cancer bone metastases
02/13/10
Tamoxifen treatment results in cognitive impairment compared to Aromasin
01/22/10
Treatment with aromatase inhibitors results in better breast cancer outcomes than tamoxifen

Studies




Breast cancer resources | Definitions | Selected supplements and vitamins | Privacy policy | Search | Tags | Disclaimer/about us | Make a donation | Sitemap